Results 171 to 180 of about 195,293 (269)

LPS role during sepsis : description of circulating LPS levels using mass spectrometry in a cohort of critically ill patients, and investigation of LDL apheresis as an alternative for extracorporeal removal .

, 2019
Auguste Dargent
openalex   +1 more source

Lipoprotein(a): structural basis, bidirectional risk, and therapeutic frontiers. [PDF]

J Clin Biochem Nutr
Xu Z, Fang Y, Peng Y, Zhang C, Zheng C.
europepmc   +1 more source

Report of the Working Group `Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)' [PDF]

, 2009
Beekes, Michael, Blümel, Johannes, Burger, Reinhard, Dewitz, Christian von, Gröner, Albrecht, Heiden, Margarethe, Kretzschmar, Hans, Nuebling, Micha, Schlenkrich, Uwe, Schottstedt, Volkmar, Seitz, Rainer, Strobel, Johanna, Willkommen, Hannelore, Wirsing von König, Carl-Heinz, Zerr, Inga   +14 more
core   +2 more sources

Aggressive cholesterol lowering and regression of atherosclerosis: studies on LDL-apheresis

, 1996
A.A. Kroon
openalex   +1 more source

Development of Selective LDL Adsorbent and LDL Apheresis System: Immobilized Polyanion as LDL-Specific Adsorbent for LDL Apheresis System

The Journal of Japan Atherosclerosis Society, 1990
openaire   +2 more sources

Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol--the role of LDL-apheresis.

Journal of Clinical Lipidology, 2013
M. McGowan
semanticscholar   +1 more source

Familial hypercholesterolemia: a history of loss but a future of hope. [PDF]

Am J Prev Cardiol
Jamison A.
europepmc   +1 more source

MONOCLONAL LDL-APHERESIS IN A FEMALE PATIENT WITH FAMILIAL HYPERCHOLESTEROLEMIA

, 1989
Д. Ненов, A. Stoyanov, P. Chankova, V. Orbetzova, G. Konovalov   +4 more
openalex   +2 more sources

Multimodal Therapy Achieves Secondary Prevention LDL-C Targets in LDL-Receptor Null Homozygous Familial Hypercholesterolemia. [PDF]

JACC Case Rep
Alkhairy A, Xiang P, Khoo JK, Taylor CM, Francis GA.   +4 more
europepmc   +1 more source

Determinants of circulating PCSK9 levels and the efficacy of PCSK9 inhibitor therapies in chronic kidney disease: a systematic review. [PDF]

Eur J Clin Pharmacol
Ábel T, Benczúr B, Csajbókné ÉC.
europepmc   +1 more source